Prelude Therapeutics Inc

CHARLES SCHWAB INVESTMENT MANAGEMENT INC PRLD

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/14/2026

Shares

67,622

Value ($000)

360

Weight

0.0%

2020 Q4 - 2026 Q2 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/14/2026	360	0.0%	67,622	6/30/2026
2025 Q2	8/12/2025	65	0.0%	80,845	6/30/2025
2025 Q1	9/15/2025	88	0.0%	114,050	3/31/2025
2024 Q4	2/6/2025	149	0.0%	117,200	12/31/2024
2024 Q3	11/12/2024	276	0.0%	133,249	9/30/2024
2024 Q2	8/12/2024	488	0.0%	128,033	6/30/2024
2024 Q1	5/9/2024	604	0.0%	127,370	3/31/2024
2023 Q4	2/6/2024	532	0.0%	124,700	12/31/2023
2023 Q3	11/8/2023	380	0.0%	123,031	9/30/2023
2023 Q2	8/10/2023	386	0.0%	85,793	6/30/2023
2023 Q1	5/12/2023	358	0.0%	62,851	3/31/2023
2022 Q4	2/13/2023	385	0.0%	63,721	12/31/2022
2022 Q3	11/14/2022	358	0.0%	54,052	9/30/2022
2022 Q2	8/15/2022	330	0.0%	63,200	6/30/2022
2022 Q1	5/13/2022	524	0.0%	75,930	3/31/2022
2021 Q4	2/11/2022	1,060	0.0%	85,137	12/31/2021
2021 Q3	11/16/2021	2,625	0.0%	83,985	9/30/2021
2021 Q2	8/16/2021	2,080	0.0%	72,623	6/30/2021
2021 Q1	5/17/2021	3,236	0.0%	74,668	3/31/2021
2020 Q4	2/16/2021	4,907	0.0%	68,568	12/31/2020